Discontinued — last reported Q2 '25
Insmed Intangible Amortization increased by 7.4% to $2.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.8%, from $1.26M to $2.08M. Over 4 years (FY 2021 to FY 2025), Intangible Amortization shows an upward trend with a 4.4% CAGR.
An increase often follows a period of aggressive M&A activity, reflecting the cost of integrating acquired intellectual property.
This metric tracks the systematic write-down of the value of acquired intangible assets, such as patents, trademarks, an...
Common in companies with high M&A activity; peers in the medical device sector typically show consistent levels.
amortization_of_intangibles| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.54M | $1.94M | $2.08M |
| QoQ Change | — | +0.1% | -0.2% | +0.1% | +0.0% | +0.0% | +0.1% | -0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +21.8% | +25.9% | +7.4% |
| YoY Change | — | — | — | — | +0.0% | -0.1% | +0.2% | +0.0% | +0.0% | +0.0% | -0.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +21.8% | +53.4% | +64.8% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|
| PARI milestones | $50.50K | $50.50K | $50.50K |
| Total | $1.26M | $1.26M | $1.26M |
| Segment | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 |
|---|---|---|---|---|---|---|---|---|
| Reportable Segment | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M |
| Total | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M | $1.26M |